clinical trial · NCT05893797
A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
Eli Lilly and Company·N/A·completed·n = 36
Type 1 DiabetesType 2 DiabetesType 2 Diabetes Treated With InsulinInsulin LisproTempo Smart ButtonDexcom G6 CGMGlooko Research Mobile App (RMA)
brief summary
The main purpose of this study is to assess participant adherence and glucose control while using a connected insulin management platform. Approximately 50 participants will be enrolled in each country.
started
Oct 5, 2023
primary completion
Sep 16, 2024
completion
Sep 16, 2024
last updated
Nov 10, 2025
official title
Assessment of Participant Adherence and Glucose Control While Using a Connected Insulin Management Platform
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol